Rapport Therapeutics, Inc. - Common Stock, $0.001 par value per share (RAPP)

Historical Holders from Q2 2024 to Q1 2025

Symbol
RAPP on Nasdaq
CUSIP
75383L102
Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
36.6M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
36.6M
Holdings value
$649M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
68
Number of buys
34
Number of sells
-17
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Rapport Therapeutics, Inc. - Common Stock, $0.001 par value per share (RAPP)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Third Rock Ventures V, L.P. 19.5% $71.6M 7.14M Third Rock Ventures V, L.P. Dec 31, 2024

Institutional Holders of Rapport Therapeutics, Inc. - Common Stock, $0.001 par value per share (RAPP)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 25.3K $254K +$151K $10.03 3
2024 Q4 36.6M $649M +$1.21M $17.74 68
2024 Q3 28.4M $580M +$35.9M $20.48 54
2024 Q2 25.6M $593M +$593M $23.26 35